Skip to main content

Table 1 Demographic and Clinical Data for the N = 74 Total Study Population

From: Exploring content and psychometric validity of newly developed assessment tools for itch and skin pain in atopic dermatitis

  Adolescents (n = 24) Adults (n = 50) Total (N = 74)
Age (years)
 Mean (SD) 13.8 (1.94) 48.4 (16.57) 37.2 (21.27)
 Median (Min-Max) 13 (12–17) 50 (19–76) 38 (12–76)
Years since diagnosis
 Mean (SD) 6.9 (4.34) 13.3 (17.40) 11.3 (14.86)
 Median (min-max) 5 (2–17) 7 (0–47) 6 (0–47)
Clinical severity, n (%)a
 Mild 8 (33.3%) 11 (22.4%) 19 (26.0%)
 Moderate 10 (41.7%) 20 (40.8%) 30 (41.1%)
 Severe 6 (25.0%) 18 (36.7%) 24 (32.9%)
Gender, n (%)
 Female 11 (45.8%) 27 (54.0%) 38 (51.4%)
 Male 13 (54.2%) 23 (46.0%) 36 (48.6%)
Race, n (%)
 White/Caucasian 10 (41.7%) 27 (54.0%) 37 (50.0%)
 Black/African American 9 (37.5%) 15 (30.0%) 24 (32.4%)
 American Indian/Alaska Native 0 (0.0%) 2 (4.0%) 2 (2.7%)
 Other/Unknown 5 (20.8%) 6 (12.0%) 11 (14.9%)
Ethnicity, n (%)
 Not Hispanic/Latino 22 (91.7%) 46 (92.0%) 68 (91.9%)
 Hispanic/Latino 2 (8.3%) 3 (6.0%) 5 (6.8%)
 Unknown 0 (0.0%) 1 (2.0%) 1 (1.4%)
Prior treatment, n (%)
 Yes 23 (95.8%) 43 (86.0%) 66 (89.2%)
 No 1 (4.2%) 7 (14.0%) 8 (10.8%)
Comorbidities
 Allergic rhinitis, n (%) 9 (37.5%) 13 (26.0%) 22 (29.7%)
 Asthma, n (%) 8 (33.3%) 11 (22.0%) 19 (25.7%)
 Food allergy, n (%) 4 (16.7%) 12 (24.0%) 16 (21.6%)
 Anxiety, n (%) 0 (0.0%) 3 (6.0%) 3 (4.1%)
 Obesity, n (%) 0 (0.0%) 3 (6.0%) 3 (4.1%)
 ADHD, n (%) 1 (4.2%) 1 (2.0%) 2 (2.7%)
Patient assessed symptom severity, n (%)
 Not Severe at All 0 (0.0%) 2 (4.0%) 2 (2.7%)
 Very Mild 1 (4.2%) 7 (14.0%) 8 (10.8%)
 Mild 13 (54.2%) 7 (14.0%) 20 (27.0%)
 Moderate 7 (29.2%) 17 (34.0%) 24 (32.4%)
 Severe 2 (8.3%) 16 (32.0%) 18 (24.3%)
 Very Severe 1 (4.2%) 1 (2.0%) 2 (2.7%)
  1. aAs assessed by a 5-point Investigator Global Assessment